Use of rituximab in the treatment of Epstein-Barr virus reactivation after allogeneic stem cell transplantation: a retrospective study in 86 patients

被引：0
|
作者：
Auger, S. [1 ]
Mines, M. L. [1 ]
Fegueux, N. [1 ]
Ceballos, P. [1 ]
Segondy, M. [1 ]
Rossi, J. -F. [1 ]
机构：
[1] St Eloi Univ Hosp, Montpellier, France
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [1] Subcutaneous administration of rituximab in patients with Epstein-Barr virus reactivation after allogeneic stem cell transplantation
    Klink, A.
    Schmidt, V.
    Dornaus, S.
    Winkelmann, N.
    Sayer, H. G.
    von Lilienfeld-Toal, M.
    Hochhaus, A.
    Hilgendod, I.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S191 - S191
  • [2] Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab
    Wei, Na
    Wang, Yini
    Wang, Jingshi
    Wu, Lin
    Wang, Zhao
    BONE MARROW TRANSPLANTATION, 2021, 56 (06) : 1449 - 1451
  • [3] Clonal gammopathies and Epstein-Barr virus reactivation after allogeneic stem cell transplantation
    Di Nardo, P.
    Bellesi, S.
    Sora, F.
    Laurenti, L.
    Innocenti, I.
    Chiusolo, P.
    Cattani, P.
    Tarnani, M.
    De Matteis, S.
    Leone, G.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S285 - S286
  • [4] Pre-emptive treatment with rituximab for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation: a safety and efficacy study
    Ganguly, S.
    DuBois, L.
    Divine, C.
    Aljitawi, O.
    Abhyankar, S.
    McGuirk, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S225 - S225
  • [5] Impact of Pre-Emptive Rituximab Treatment for Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Longitudinal Study of 110 Patients
    Stocker, Nicolas
    Labopin, Myriam
    Boussen, Ines
    Lamarthee, Baptiste
    Malard, Florent
    Bonnin, Agnes
    Marechal, Vincent
    Amiel, Corinne
    Quignon, Frederique
    Gozlan, Joel
    Battipaglia, Giorgia
    Dulery, Remy
    Giannotti, Federica
    Ruggeri, Annalisa
    Gaugler, Beatrice
    Mohty, Mohamad
    Brissot, Eolia
    BLOOD, 2017, 130
  • [6] Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation
    Petropoulou, Anna D.
    Porcher, Raphael
    de Latour, Regis Peffault
    Xhaard, Alienor
    Weisdorf, Daniel
    Ribaud, Patricia
    Rodriguez-Otero, Paula
    Agbalika, Felix
    Talbot, Alexis
    Toubert, Antoine
    Moins-Teisserenc, Helene
    Carmagnat, Maryvonnick
    Socie, Gerard
    Robin, Marie
    TRANSPLANTATION, 2012, 94 (08) : 879 - 883
  • [7] Management of Epstein-Barr virus reactivation following allogeneic stem cell transplantation
    Lankester, Arjan C.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (03) : 163 - 165
  • [8] Use of Rituximab in Epstein-Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation
    Song, Li
    Wang, Pei-Jun
    Zhang, Mei-Ping
    Ji, Chun-Xiao
    Wang, Ling
    Li, Ying
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (05): : 2439 - 2443
  • [9] Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation
    Zallio, Francesco
    Primon, Valeria
    Tamiazzo, Stefania
    Pini, Massimo
    Baraldi, Anna
    Corsetti, Maria T.
    Gotta, Franca
    Bertassello, Claudia
    Salvi, Flavia
    Rocchetti, Andrea
    Levis, Alessandro
    CLINICAL TRANSPLANTATION, 2013, 27 (04) : E491 - E497
  • [10] Increased infection rate after pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation
    Petropoulou, A.
    Porcher, R.
    de Latour, R. Peffault
    Xhaard, A.
    Ribaud, P.
    Rodriguez-Otero, P.
    Toubert, A.
    Carmagnat, M.
    Socie, G.
    Robin, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S80 - S81
12345